128 related articles for article (PubMed ID: 37599474)
1. Theoretical insights into the binding interaction of Nirmatrelvir with SARS-CoV-2 Mpro mutants (C145A and C145S): MD simulations and binding free-energy calculation to understand drug resistance.
Purohit P; Panda M; Muya JT; Bandyopadhyay P; Meher BR
J Biomol Struct Dyn; 2023 Aug; ():1-20. PubMed ID: 37599474
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors.
Kovalevsky A; Aniana A; Coates L; Bonnesen PV; Nashed NT; Louis JM
J Biol Chem; 2023 Jul; 299(7):104886. PubMed ID: 37271339
[TBL] [Abstract][Full Text] [Related]
3. Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study.
Uzuner U; Akkus E; Kocak A; Çelik Uzuner S
J Biomol Struct Dyn; 2023 Jul; ():1-12. PubMed ID: 37458994
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
Purohit P; Dash JJ; Muya JT; Meher BR
J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
[TBL] [Abstract][Full Text] [Related]
5. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
Ancy I; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2021 Sep; 39(15):5368-5375. PubMed ID: 32627689
[TBL] [Abstract][Full Text] [Related]
6. Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from
Al-Karmalawy AA; Alnajjar R; Elmaaty AA; Binjubair FA; Al-Rashood ST; Mansour BS; Elkamhawy A; Eldehna WM; Mansour KA
J Biomol Struct Dyn; 2023 Jul; ():1-13. PubMed ID: 37505066
[TBL] [Abstract][Full Text] [Related]
7. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
[TBL] [Abstract][Full Text] [Related]
8. Chemical constituents from coconut waste and their
Elsbaey M; Ibrahim MAA; Bar FA; Elgazar AA
S Afr J Bot; 2021 Sep; 141():278-289. PubMed ID: 34092840
[TBL] [Abstract][Full Text] [Related]
9. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.
Paciaroni A; Libera V; Ripanti F; Orecchini A; Petrillo C; Francisci D; Schiaroli E; Sabbatini S; Gidari A; Bianconi E; Macchiarulo A; Hussain R; Silvestrini L; Moretti P; Belhaj N; Vercelli M; Roque Y; Mariani P; Comez L; Spinozzi F
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047038
[TBL] [Abstract][Full Text] [Related]
11. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.
Andrianov AM; Kornoushenko YV; Karpenko AD; Bosko IP; Tuzikov AV
J Biomol Struct Dyn; 2021 Sep; 39(15):5779-5791. PubMed ID: 32662333
[TBL] [Abstract][Full Text] [Related]
12. Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.
Zakharova MY; Kuznetsova AA; Uvarova VI; Fomina AD; Kozlovskaya LI; Kaliberda EN; Kurbatskaia IN; Smirnov IV; Bulygin AA; Knorre VD; Fedorova OS; Varnek A; Osolodkin DI; Ishmukhametov AA; Egorov AM; Gabibov AG; Kuznetsov NA
Front Pharmacol; 2021; 12():773198. PubMed ID: 34938188
[TBL] [Abstract][Full Text] [Related]
13. Targeting allosteric pockets of SARS-CoV-2 main protease M
Bhat ZA; Chitara D; Iqbal J; Sanjeev BS; Madhumalar A
J Biomol Struct Dyn; 2022 Sep; 40(14):6603-6618. PubMed ID: 33645457
[TBL] [Abstract][Full Text] [Related]
14. Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings.
Avti P; Chauhan A; Shekhar N; Prajapat M; Sarma P; Kaur H; Bhattacharyya A; Kumar S; Prakash A; Sharma S; Medhi B
J Biomol Struct Dyn; 2022; 40(19):8894-8904. PubMed ID: 33998950
[TBL] [Abstract][Full Text] [Related]
15. The binding mechanism of failed, in processing and succeed inhibitors target SARS-CoV-2 main protease.
Hongyu H; Wu T; He F; Chao M; Huang J; Wang X; Niu Z; Tang B
J Biomol Struct Dyn; 2023 Sep; ():1-12. PubMed ID: 37735887
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
[TBL] [Abstract][Full Text] [Related]
17. Identification of prospective covalent inhibitors for SARS-CoV-2 main protease using structure-based approach.
Gayatri SK; Chhabra V; Kumar H; Sobhia ME
J Biomol Struct Dyn; 2023; 41(16):7913-7930. PubMed ID: 36200615
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of main protease (M
Jiang H; Zou X; Zeng P; Zeng X; Zhou X; Wang J; Zhang J; Li J
Mol Biomed; 2023 Aug; 4(1):23. PubMed ID: 37532968
[TBL] [Abstract][Full Text] [Related]
19. Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M
Kakhar Umar A; Zothantluanga JH; Luckanagul JA; Limpikirati P; Sriwidodo S
PeerJ; 2023; 11():e14915. PubMed ID: 36935912
[TBL] [Abstract][Full Text] [Related]
20. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
